Forest Laboratories, Inc. http://www.alacrastore.com/company-snapshot/Forest_Laboratories_Inc-1006548 27 Nov 2009 05:43:38 EST 1006548 Forest Laboratories, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T2555603T2555603ccbn/T2555603norm17 Nov 2009 01:06:55 EST2555603Final Transcript of FRX presentation, 17-Nov-09 10:25am ETForest Laboratories, Inc.106.0000FinalForest Laboratories, Inc. at Lazard Capital Healthcare Conference TranscriptFRX10:25am ETTranscript...Unidentified Participant (Audio in progress) Forest Labs is one of our [biorated] stocks for us certainly, a big cap [speck pharm], one of our top picks and pleased to have I guess -- Unidentified Participant Frank is not here yet. Unidentified Participant Frank Murdolo, who is the Director of Investor Relations and Larry Olanoff, who is the President and Chief Operating Officer presenting for Forest. And so the format will be a few slides, sort of a brief introduction of the Company; although I am sure most people know it. And then we would like to open it up for hopefully some feisty audience participation. So Larry? Larry Olanoff - Forest Laboratories, Inc. - President & COO If you are not feisty, you should leave now. Thank you for the opportunity. I'm going to show a few slides. I am going to rush through them a little bit to give you a little more time for the Q&A, but I want to make sure everybody understands our business model and how we see ourselves going forward in the future.... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2550782T2550782ccbn/T2550782norm12 Nov 2009 03:08:00 EST2550782Final Transcript of FRX presentation, 12-Nov-09 1:30pm ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at Credit Suisse Healthcare Conference TranscriptFRX1:30pm ETTranscript...Unidentified Participant All right. We will kick off the next presentation, which is Forest Laboratories and presenting for the Company today is the President and COO, Larry Olanoff. Larry, I will turn it over to you. Larry Olanoff - Forest Laboratories, Inc. - President & COO Good morning. It is a great opportunity to talk to the audience today and update our story a bit. I am assuming that many of you are aware of Forest and our business model, but I will spend a little bit of time describing that as well. But I will spend most of my time talking about the development portfolio and some of our recently launched products. I'll start off with the standard Safe Harbor statement. Except for historical information contained herein, the presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of ####. And I would welcome those on the webcast for further detail to look at our website in this regard. Forest's business model has been pretty... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39037837BW-0001-39037837newstex/BW-0001-39037837xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-39037837Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004016000040160480401601804016001040020000400200621 Oct 2009 05:23:37 EST18000000180080001800400010/21/2009 Oct. ##, #### (Business Wire) -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks...BIOGEN IDEC INCFOREST LABORATORIES INCUNITEDHEALTH GROUP INCBIIBFRXUNHNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2477833B2477833ccbn/B2477833norm20 Oct 2009 12:06:00 EST2477833Edited Brief of FRX earnings conference call or presentation, 20-Oct-09 10:00am ETForest Laboratories, Inc.54.0000EditedForest Laboratories, Inc. Q2 2010 Earnings Conference Call SummaryFRX10:00am ETBrief...Frank Murdolo Forest Laboratories, Inc. - IR Larry Olanoff Forest Laboratories, Inc. - COO Frank Perier Forest Laboratories, Inc. - CFO... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2477833T2477833ccbn/T2477833norm20 Oct 2009 12:06:00 EST2477833Final Transcript of FRX earnings conference call or presentation, 20-Oct-09 10:00am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. Q2 2010 Earnings Conference Call TranscriptFRX10:00am ETTranscript...Frank Murdolo Forest Laboratories, Inc. - IR Larry Olanoff Forest Laboratories, Inc. - COO Frank Perier Forest Laboratories, Inc. - CFO... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-38619894BW-0001-38619894newstex/BW-0001-38619894xmlNewstex Inc.2005Pennsylvania BioNewstex Inc.newstex.comnewstexBW-0001-38619894Business Wire0001Business WireBW1Newstex Inc.Business Wire09000000090150000400000004016000040160080400200004002006070000000701400007014012070030000700300111000000110060001100600813000000130100001301000507 Oct 2009 03:24:26 EST180000001800700019000000190010001900103810/7/2009 Oct. #, #### (Business Wire) -- Pennsylvania Bio ( www.pennsylvaniabio.org ), the statewide Association representing Pennsylvania’s biosciences community, today announced the appointment of two new members to its Board of Directors:...ENDO PHARMACEUTICALS HOLDINGS INCFOREST LABORATORIES INCIvan GergelJoseph C ScodariENDPFRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38536410BW-0001-38536410newstex/BW-0001-38536410xmlNewstex Inc.2005Forest Laboratories, Inc.Newstex Inc.newstex.comnewstexBW-0001-38536410Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004002000040020060401600004016048040160010401601807000000070140000701401205 Oct 2009 09:40:56 EST18000000180080001800400010/5/2009 Oct. #, #### (Business Wire) -- Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, will release its Fiscal #### Second Quarter financial results before the U.S. stock market...FOREST LABORATORIES INCLAWRENCE S OLANOFFFRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38337166BW-0001-38337166newstex/BW-0001-38337166xmlNewstex Inc.2005Pappas VenturesNewstex Inc.newstex.comnewstexBW-0001-38337166Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040170000400200004002006040060000400600104016000040160130700000007014000070140120700300007003001130000001301000013010005130020001300200528 Sep 2009 09:40:06 EST18000000180160009/28/2009 Sep. ##, #### (Business Wire) -- Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner. As managing partner, Linsley will play an enhanced leadership role on a team of investment, biotechnology...FOREST LABORATORIES INCJOHNSON & JOHNSONPANACOS PHARMACEUTICALS INCERIC W LINSLEYFRXJNJPANCNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T2400897T2400897ccbn/T2400897norm15 Sep 2009 12:06:00 EST2400897Final Transcript of FRX presentation, 15-Sep-09 10:20am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at Morgan Stanley Global Healthcare Conference TranscriptFRX10:20am ETTranscript...Unidentified Participant Okay, so we should probably get started. I am just going to give a very brief for introduction for Frank Perier who I'm sure many of you know. Frank originally joined Forest in ####. Before Forest, he was at Bristol for eight years where he served as Vice ... division. And prior to Bristol, he was a partner at Deloitte. And so it is very much my pleasure to welcome Frank. I will kick it off with a question or two. Feel free to please ask questions. So I guess my first question is clearly you have a strong cash position that the investment community wants you to leverage. Management is conservative, but it is a huge amount of cash for you to put to work. So maybe you could talk first about the ... use of cash going forward. And second, if you could specifically... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-37928236BW-0001-37928236newstex/BW-0001-37928236xmlNewstex Inc.2005Forest Laboratories, Inc.Newstex Inc.newstex.comnewstexBW-0001-37928236Business Wire0001Business WireBW1Newstex Inc.Business Wire070000000700500007013000140000001400300004000000040020000400200607001000070010010700300007003001070140000701401213000000130100001301000513 Sep 2009 01:22:44 EST1800000018016000180200001900000019001000190020001900200719002008190020049/13/2009 Sep. ##, #### (Business Wire) -- Forest Laboratories, Inc (NYSE: FRX) today presented at the ## th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS...FOREST LABORATORIES INCFRXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T2431042T2431042ccbn/T2431042norm09 Sep 2009 02:06:00 EST2431042Final Transcript of FRX presentation, 9-Sep-09 8:30am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at Robert W. Baird & Co., Inc. Health Care Conference TranscriptFRX8:30am ETTranscript...Tom Russo - Robert W. Baird - Analyst Good morning, everyone. We are delighted to welcome you to Baird's #### healthcare conference. Baird has significantly expanded its healthcare research team, which now includes seven senior analysts and a total of ## professionals. This conference will feature formal presentations from ## public and private companies from the following sectors -- biotechnology distribution and services, life sciences and diagnostics, medical technology and specialty pharmaceuticals. In addition, you will have access to management and breakout sessions and small group meetings. During this unique time of pending changes in healthcare reform, this conference will provide an opportunity to visit with healthcare executives and gather their insights on the key issues they face. The conference is designed to be a platform for you to find new ideas, as well as to get updates on your current holdings. We are proud to note that while much is changing in our industry, the way... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2411225T2411225ccbn/T2411225norm28 Aug 2009 04:05:00 EST2411225Final Transcript of FRX conference call or presentation, 28-Aug-09 7:15am ETForest Laboratories, Inc.54.0000FinalConference Call to Review Publication of Daxas Ph. III Clinical Trial Results TranscriptFRX7:15am ETTranscript...Frank Murdolo Forest Laboratories, Inc. - VP - IR Dr. Anders Ullman Nycomed - EVP, R&D Fernando Martinez University of Michigan - Professor Dr. Lawrence Olanoff Forest Laboratories, Inc. - President and COO C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2411225B2411225ccbn/B2411225norm28 Aug 2009 11:05:00 EST2411225Edited Brief of FRX conference call or presentation, 28-Aug-09 7:15am ETForest Laboratories, Inc.54.0000EditedConference Call to Review Publication of Daxas Ph. III Clinical Trial Results SummaryFRX7:15am ETBrief...Frank Murdolo Forest Laboratories, Inc. - VP - IR Dr. Anders Ullman Nycomed - EVP, R&D Fernando Martinez University of Michigan - Professor Dr. Lawrence Olanoff Forest Laboratories, Inc. - President and COO CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-37549896BW-0001-37549896newstex/BW-0001-37549896xmlNewstex Inc.2005Forest Laboratories, Inc.Newstex Inc.newstex.comnewstexBW-0001-37549896Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004002000040020060401600004016048070000000701400007014012070030000700300113000000130100001301000527 Aug 2009 07:21:13 EST180000001802000018008000180040008/27/2009 Aug. ##, #### (Business Wire) -- Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products and Nycomed, a privately owned pharmaceutical company, will host a conference call at #:##...FOREST LABORATORIES INCLAWRENCE S OLANOFFMarco TagliettiFRXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2315513B2315513ccbn/B2315513norm21 Jul 2009 02:07:00 EST2315513Edited Brief of FRX earnings conference call or presentation, 21-Jul-09 10:00am ETForest Laboratories, Inc.54.0000EditedForest Laboratories, Inc. Q1 2010 Earnings Conference Call SummaryFRX10:00am ETBrief...Frank Murdolo Forest Laboratories, Inc. - VP of IR Larry Olanoff Foerst Laboratories, Inc. - President & COO Frank Perier Forest Laboratories, Inc. - CFO & SVP Finance CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2315513T2315513ccbn/T2315513norm21 Jul 2009 12:07:00 EST2315513Final Transcript of FRX earnings conference call or presentation, 21-Jul-09 10:00am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. Q1 2010 Earnings Conference Call TranscriptFRX10:00am ETTranscript...Frank Murdolo Forest Laboratories, Inc. - VP of IR Larry Olanoff Foerst Laboratories, Inc. - President & COO Frank Perier Forest Laboratories, Inc. - CFO & SVP Finance C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventsUS - Caraco Pharmaceutical Laboratories Ltd agreed to acquire the Inwood business products of Forest Laboratories Inc, a New York- based manufacturer and wholesaler of prescription pharmaceuticals.11 Jul 2009 06:32:01 EST14075T34583E14075T345838Caraco Pharmaceutical Laboratories LtdForest Laboratories Inc-Inwood Business ProductsCaraco Pharmaceutical Laboratories LtdForest Laboratories Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Caraco_Pharmaceutical_Labs_Ltd_acquires_Forest_Laboratories_Inc_Inwood_from_Forest_Laboratories_Inc-2090032020sdc/20900320202090032020Copyright © 2009, Thomson Financial, All Rights ReservedAmericanDrugsUnited StatesPharmaceutical preparations2834MIMichiganPublicCPD2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substancesDrugsUnited StatesPharmaceutical preparations2834NYNew YorkSubsidiary260089001Mnfr pharmMnfr,whl pharmUnspecifiedAssets1093330001Jul 11 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000Caraco PharmaceuticalLaboratories Ltd, located inDetroit, Michigan,manufactures prescriptionpharmaceuticals intended forfinal consumption, includingbiotech products andantibiotics. The company wasfounded in 1984.Caraco Pharmaceutical Laboratories Ltd, located in Detroit,Michigan, manufactures prescription pharmaceuticals intendedfor final consumption, including biotech products andantibiotics. The company was founded in 1984.Caraco Pharmaceutical Laboratories Ltd, located in Detroit, Michigan, manufactures prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics. The company was founded in 1984.1.000002.000003.000004.00000The Inwood business productsof Forest Laboratories Incmanufacture and wholesaleprescription pharmaceuticals.The Inwood business products of Forest Laboratories Incmanufacture and wholesale prescription pharmaceuticals.The Inwood business products of Forest Laboratories Inc manufacture and wholesale prescription pharmaceuticals.0.000000.000000.000000.00000N10 Jul 09Fri, 10 Jul 2009 00:00:00 ESTDate Announced: 07/10/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.00000US - Caraco PharmaceuticalLaboratories Ltd agreed toacquire the Inwood businessproducts of ForestLaboratories Inc, a New York-based manufacturer andwholesaler of prescriptionpharmaceuticals.US - Caraco Pharmaceutical Laboratories Ltd agreed to acquire the Inwood business products of Forest Laboratories Inc, a New York- based manufacturer and wholesaler of prescription pharmaceuticals.US - Caraco Pharmaceutical Laboratories Ltd agreed to acquire the Inwood business productsof Forest Laboratories Inc, a New York- based manufacturer and wholesaler of prescriptionpharmaceuticals.US - Caraco Pharmaceutical Laboratories Ltd agreed to acquire the Inwood business products of Forest Laboratories Inc, a New York- based manufacturer and wholesaler of prescription pharmaceuticals.US - Caraco Pharmaceutical Laboratories Ltd agreed to acquire the Inwood business products of Forest Laboratories Inc, a New York- basedmanufacturer and wholesaler of prescription pharmaceuticals.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries6719:Offices of holding companies, nec8731:Commercial physical and biological research260089001AmericanUnited States2834MichiganPublicCPD2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries6719:Offices of holding companies, nec8731:Commercial physical and biological research2377001New YorkUnited States2834New YorkPublicFRX0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T2282295T2282295ccbn/T2282295norm17 Jun 2009 03:04:00 EST2282295Final Transcript of FRX presentation, 17-Jun-09 1:30pm ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at Jefferies & Co. Healthcare Conference TranscriptFRX1:30pm ETTranscript...David Windley - Jefferies & Company - Analyst Before I get too far behind schedule here, I want to keep things moving along. The next presenter is Forest Laboratories. This is the Track B #:## time slot. Here to present for Forest Labs is Frank Perier. He is the Company's Chief Financial Officer. As you probably know, Forest is based here in Manhattan and is a pharmaceutical company focused in the primary care arena across a number of therapeutic areas. So I'm going to turn the presentation, the podium over to Frank. Thanks. Frank Perier - Forest Laboratories, Inc. - CFO Dave, thank you very much for the introduction, and good afternoon, everyone. It is a pleasure to be here. Hope you're enjoying there's some decent weather in Manhattan for a change. By way of introduction, I just want to start off with kind of the standard Safe Harbor, that the remarks I'm about to make do contain forward-looking information as defined within the Private Securities Litigation Reform Act, and I would refer... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2256467T2256467ccbn/T2256467norm02 Jun 2009 03:04:00 EST2256467Final Transcript of FRX presentation, 2-Jun-09 8:00am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at UBS Global Specialty Pharmaceuticals Conference TranscriptFRX8:00am ETTranscript...Frank Perier - Forest Laboratories - CFO Good afternoon all, it's a great pleasure to be here with you this afternoon in London. It's always a special treat to be the first speaker after lunch, so please do stick with me. Just as a point of housekeeping, I just wanted to quickly go through our Safe Harbor. The presentation does include some forward-looking statements and information as defined by the Private Securities Reform Act of ####. I would refer you to the complete Safe Harbor statement that we have on our website. ... a tremendous amount of success in the US pharmaceutical marketplace which is our principle area of expertise, our business is very highly concentrated in the United States and we're very strategically focused on basically four key tenets. One is supporting the growth and the in-line performance of our currently marketed products which includes Lexapro for the... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2222387T2222387ccbn/T2222387norm13 May 2009 04:06:00 EST2222387Final Transcript of FRX presentation, 13-May-09 11:20am ETForest Laboratories, Inc.54.0000FinalForest Laboratories, Inc. at Bank of America Securities Healthcare Conference TranscriptFRX11:20am ETTranscript...Greg Gilbert - Bank of America - Analyst I'm happy to have Forest Labs here to be the next presenting company. Dr. Larry Olanoff is currently President and Chief Operating Officer and a Director of Forest Labs, having rejoined the Company in late ####. He served as President and CEO of Celsion Corporation from July '## to October '##. From #### until July of ####, Dr. Olanoff was responsible for the leadership of research and development for Forest, ultimately as its EVP Scientific Affairs. From #### to '##, Larry was Senior Vice President Clinical Research and Development and Sandoz Corporation, and from #### to #### he was employed by the Upjohn Company, where his last position was Corporate Vice President Clinical Development and Medical Affairs. So what we've asked Larry to do is walk us through briskly through the Forest story. We are fortunate to also have Frank Perier, the CFO, here with us to help handle Q&A, and without further ado, I will turn it over to Larry and thank you very... Credit & Investment ResearchThomson StreetEvents